IBDEI0N5 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10302,1,4,0)
 ;;=4^S02.81XA
 ;;^UTILITY(U,$J,358.3,10302,2)
 ;;=^5139523
 ;;^UTILITY(U,$J,358.3,10303,0)
 ;;=S02.82XA^^74^675^14
 ;;^UTILITY(U,$J,358.3,10303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10303,1,3,0)
 ;;=3^Fx of Skull/Facial Bones,Left Side,Init Encntr for Closed Fx
 ;;^UTILITY(U,$J,358.3,10303,1,4,0)
 ;;=4^S02.82XA
 ;;^UTILITY(U,$J,358.3,10303,2)
 ;;=^5139529
 ;;^UTILITY(U,$J,358.3,10304,0)
 ;;=S02.31XA^^74^675^15
 ;;^UTILITY(U,$J,358.3,10304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10304,1,3,0)
 ;;=3^Fx of Orbital Floor,Right Side,Init Encntr for Closed Fx
 ;;^UTILITY(U,$J,358.3,10304,1,4,0)
 ;;=4^S02.31XA
 ;;^UTILITY(U,$J,358.3,10304,2)
 ;;=^5139325
 ;;^UTILITY(U,$J,358.3,10305,0)
 ;;=S02.32XA^^74^675^16
 ;;^UTILITY(U,$J,358.3,10305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10305,1,3,0)
 ;;=3^Fx of Orbital Floor,Left Side,Init Encntr for Closed Fx
 ;;^UTILITY(U,$J,358.3,10305,1,4,0)
 ;;=4^S02.32XA
 ;;^UTILITY(U,$J,358.3,10305,2)
 ;;=^5139331
 ;;^UTILITY(U,$J,358.3,10306,0)
 ;;=H04.123^^74^676^1
 ;;^UTILITY(U,$J,358.3,10306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10306,1,3,0)
 ;;=3^Dry Eye Syndrome,Bilateral Lacrimal Glands
 ;;^UTILITY(U,$J,358.3,10306,1,4,0)
 ;;=4^H04.123
 ;;^UTILITY(U,$J,358.3,10306,2)
 ;;=^5004465
 ;;^UTILITY(U,$J,358.3,10307,0)
 ;;=M35.01^^74^676^2
 ;;^UTILITY(U,$J,358.3,10307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10307,1,3,0)
 ;;=3^Sicca Syndrome w/ Keratoconjunctivitis
 ;;^UTILITY(U,$J,358.3,10307,1,4,0)
 ;;=4^M35.01
 ;;^UTILITY(U,$J,358.3,10307,2)
 ;;=^5011787
 ;;^UTILITY(U,$J,358.3,10308,0)
 ;;=H10.503^^74^676^3
 ;;^UTILITY(U,$J,358.3,10308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10308,1,3,0)
 ;;=3^Blepharoconjunctivitis,Bilateral
 ;;^UTILITY(U,$J,358.3,10308,1,4,0)
 ;;=4^H10.503
 ;;^UTILITY(U,$J,358.3,10308,2)
 ;;=^5004699
 ;;^UTILITY(U,$J,358.3,10309,0)
 ;;=H01.001^^74^676^4
 ;;^UTILITY(U,$J,358.3,10309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10309,1,3,0)
 ;;=3^Blepharitis,Right Upper Eyelid
 ;;^UTILITY(U,$J,358.3,10309,1,4,0)
 ;;=4^H01.001
 ;;^UTILITY(U,$J,358.3,10309,2)
 ;;=^5004238
 ;;^UTILITY(U,$J,358.3,10310,0)
 ;;=H01.004^^74^676^5
 ;;^UTILITY(U,$J,358.3,10310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10310,1,3,0)
 ;;=3^Blepharitis,Left Upper Eyelid
 ;;^UTILITY(U,$J,358.3,10310,1,4,0)
 ;;=4^H01.004
 ;;^UTILITY(U,$J,358.3,10310,2)
 ;;=^5004241
 ;;^UTILITY(U,$J,358.3,10311,0)
 ;;=L71.9^^74^676^6
 ;;^UTILITY(U,$J,358.3,10311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10311,1,3,0)
 ;;=3^Rosacea,Unspec
 ;;^UTILITY(U,$J,358.3,10311,1,4,0)
 ;;=4^L71.9
 ;;^UTILITY(U,$J,358.3,10311,2)
 ;;=^5009276
 ;;^UTILITY(U,$J,358.3,10312,0)
 ;;=H04.221^^74^676^10
 ;;^UTILITY(U,$J,358.3,10312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10312,1,3,0)
 ;;=3^Epiphora d/t Insuff Drainage,Right 
 ;;^UTILITY(U,$J,358.3,10312,1,4,0)
 ;;=4^H04.221
 ;;^UTILITY(U,$J,358.3,10312,2)
 ;;=^5004491
 ;;^UTILITY(U,$J,358.3,10313,0)
 ;;=H04.222^^74^676^11
 ;;^UTILITY(U,$J,358.3,10313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10313,1,3,0)
 ;;=3^Epiphora d/t Insuff Drainage,Left 
 ;;^UTILITY(U,$J,358.3,10313,1,4,0)
 ;;=4^H04.222
 ;;^UTILITY(U,$J,358.3,10313,2)
 ;;=^5004492
 ;;^UTILITY(U,$J,358.3,10314,0)
 ;;=H04.551^^74^676^12
 ;;^UTILITY(U,$J,358.3,10314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10314,1,3,0)
 ;;=3^Acquired Stenosis,Right Nasolacrimal Duct
